Tradegate
09.04.26 | 09:12
4,360 Euro
-1,25 % -0,055
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,355 | 4,510 | 08:00 | |
| 4,390 | 4,445 | 08:00 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2026 | 264 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 18.03. | Median Technologies Achieves ISO 13485:2016 Certification for eyonis Medical Device Quality Management System | 357 | Business Wire | Certification of a robust and compliant Quality Management System for AI-based Software as Medical Devices, as per internationally recognized medical device regulatory standards
Pledge... ► Artikel lesen | |
| 13.03. | Median Technologies Meets the Eligibility Conditions for the PEA-PME Scheme | 336 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as... ► Artikel lesen | |
| 09.03. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2026 | 281 | Business Wire | Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 02.03. | Median Technologies to Showcase eyonis LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Congress of Radiology | 385 | Business Wire | eyonis LCS commercial launch is ongoing in U.S. following FDA 510(k) clearance
CE-marking regulatory process is on-going with a decision expected in Q2 2026 that could trigger commercial... ► Artikel lesen | |
| MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 27.02. | Median Technologies to present at the TD Cowen 46th Annual Health Care Conference | 363 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for... ► Artikel lesen | |
| 23.02. | Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis LCS | 289 | Business Wire | Webcasts on February 26, 2026, at 5:45 pm CET (held in French): sign-up link and 6:45 pm CET/12:45 pm ET (held in English): sign-up link
Regulatory News:
Median Technologies (FR0011049824, ALMDT... ► Artikel lesen | |
| 18.02. | Median Technologies: FDA Clearance Sets Stage for U.S. Commercialization of eyonis LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu Appointed President of Median eyonis Inc. | 555 | Business Wire | Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS
Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway... ► Artikel lesen | |
| 12.02. | Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States | 422 | Business Wire | The collaboration follows FDA 510(k) clearance for eyonis LCS and aims to integrate high-performance lung cancer screening detection and diagnosis device into the clinical workflow through the Tempus... ► Artikel lesen | |
| 11.02. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026 | 360 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 09.02. | Median Technologies receives FDA clearance for lung cancer AI tool | 8 | Investing.com | ||
| 09.02. | Median Technologies Receives FDA 510(k) Clearance for eyonis LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer Screening | 606 | Business Wire | eyonis LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unnecessary follow-up procedures, and has the potential... ► Artikel lesen | |
| 19.01. | Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026 | 370 | Business Wire | Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of (6.5) million
2025 revenue of €23.5 million, up 2.6% vs 2024 despite negative... ► Artikel lesen | |
| 14.01. | Median Technologies: H1 2026 Financial Communication Calendar | 371 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), manufacturer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
| 07.01. | Half Year Median Technologies Liquidity Contract Statement | 631 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were... ► Artikel lesen | |
| 05.01. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31, 2025 | 302 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
| 08.12.25 | Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis LCS to Patients Across the U.S. and Europe | 372 | Business Wire | Non-exclusive commercial agreement for the distribution of eyonis LCS in the United States and Europe
The agreement will become effective upon FDA 510(k) clearance
Partner's robust... ► Artikel lesen | |
| 03.12.25 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025 | 364 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
| 25.11.25 | Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis LCS for Lung Cancer Screening at the RSNA 2025 Annual Meeting | 482 | Business Wire | Peer-reviewed scientific presentation: "Rethinking Lung Cancer Screening: Longitudinal AI/ML Diagnostics beyond Nodule Size Growth"
AI Theater Presentation: "eyonis LCS: Transforming Lung... ► Artikel lesen | |
| 13.11.25 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2025 | 370 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PALANTIR TECHNOLOGIES | 112,22 | +0,63 % | Micheal Burry rechnet ab: Tesla, Palantir & Co: Gewinne wirken größer - Millionen Anleger checken es nicht | © Foto: Imago Images / ZUMA Press WireElon Musks Vergütung spielt in einer eigenen Liga - und genau das wirkt sich auf die Gewinne aus. Laut Michael Burry übersehen viele Anleger, was dabei im Hintergrund... ► Artikel lesen | |
| ORACLE | 118,06 | +0,20 % | Oracle vollzieht strategische Wende: Warum der Markt den Multicloud-Schwenk neu bewerten muss | Oracle steht vor einem möglichen Bewertungsumschwung: Die starke Dynamik der Cloud-Sparte OCI, eine klar erkennbare Multicloud-Strategie und ein sich verbesserndes Wachstumsprofil könnten die bisher... ► Artikel lesen | |
| SHOPIFY | 97,30 | +1,36 % | Shopify-Aktie: Große Kaufchance nach Kursrückgang | Im Oktober vergangenen Jahres erreichte die Shopify-Aktie ihr vorläufiges Langzeithoch bei Kursen über 180 US-Dollar. Von diesem Niveau hat der Titel mittlerweile wieder rund 35 Prozent korrigiert.... ► Artikel lesen | |
| CROWDSTRIKE | 339,80 | +0,76 % | CrowdStrike: KI-Partnerschaft mit Anthropic setzt neue Maßstäbe in der Cyberabwehr | Ein KI-Projekt mit Anthropic katapultiert CrowdStrike ins Rampenlicht der Cybersicherheitsbranche. Die Aktie profitiert kräftig - Analysten sehen Potenzial für die Zukunft. So prognostiziert das technische... ► Artikel lesen | |
| D-WAVE QUANTUM | 11,925 | +0,46 % | Beyond AI: Sind Quantum-Aktien das nächste große Tech-Thema? SuperQ und D-Wave im Fokus | ||
| ATOSS SOFTWARE | 74,50 | 0,00 % | PTA-News: NWN Nebenwerte Nachrichten AG: Atoss Software SE - Im Strudel der Software-Skepsis - Atoss liefert Rekordzahlen ab. Doch an der Börse interessieren Fundamentaldaten derzeit wenig. | DJ PTA-News: NWN Nebenwerte Nachrichten AG: Atoss Software SE - Im Strudel der Software-Skepsis - Atoss liefert Rekordzahlen ab. Doch an der Börse interessieren Fundamentaldaten derzeit wenig.
... ► Artikel lesen | |
| ZOOM COMMUNICATIONS | 72,46 | +0,88 % | Zoom dips after a six-session rally | ||
| VEEVA SYSTEMS | 134,45 | +0,15 % | RegASK & Veeva Systems Partner to Boost RIM Intelligence Capabilities | ||
| BRAINCHIP | 0,089 | +0,23 % | BrainChip Holdings Ltd: BrainChip Enables the Next Generation of Always-On Wearables With the AkidaTag© Reference Platform | New Platform for wearable AI and industrial uses combines the company's Akida AKD1500 neuromorphic co-processor silicon with Nordic Semiconductor's nRF5340 wireless SoC for intelligent low-power... ► Artikel lesen | |
| GEN DIGITAL | 15,566 | -0,83 % | Gen Digital Inc.: Helping Students Understand AI in the Classroom | Gen partners with Discovery Education on new video series focused on AI literacy NORTHAMPTON, MA / ACCESS Newswire / April 7, 2026 / by Kim Allman | Head of Corporate Responsibility and Public PolicyGen... ► Artikel lesen | |
| VERSES AI | 0,498 | 0,00 % | VERSES AI Inc.: VERSES AI Corporation Restructures to Focus on Core Target Market | VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next-generation... ► Artikel lesen | |
| GRAB | 3,177 | +0,89 % | Grab Holdings (GRAB): The Best Strong Buy Asian Stock to Invest In | ||
| SENTINELONE | 10,870 | -0,46 % | SentinelOne (S) is One of the Best Mid-Cap Growth Stocks to Invest in, Here is Why | ||
| TREND MICRO | 28,810 | -0,24 % | Trend Micro ist jetzt TrendAI | ||
| MITEK SYSTEMS | 11,910 | -1,57 % | Mitek Systems: Mitek Strengthens Its Unassisted Video Verification Solution for the Spanish Market as AI-Driven Identity Fraud Accelerates | SEPBLAC-compliant digital onboarding helps regulated entities stay ahead of deepfakes and digital manipulation without adding friction
Mitek Systems (NASDAQ: MITK), a global leader in digital identity... ► Artikel lesen |
Das Unternehmen MEDIAN TECHNOLOGIES kann der Branche Software zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,25 % bei einem Aktienkurs von 4,360 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MEDIAN TECHNOLOGIES finden Sie auf Wallstreet Online.